Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441335 · ClinicalTrials.gov registry record
CellulaR Injury and Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 705
- Enrollment target
NCT02441335: Completed study, sponsored by University of Pennsylvania.
NCT02441335 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 705 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02441335 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 705 participants
- Enrollment target
Study Summary
The goal of this study is to examine how cellular dysfunction can lead to preterm birth. Women with singleton pregnancies with spontaneous preterm labor, preterm premature rupture of membranes, and cervical insufficiency (20 to 36-6/7 weeks gestation), and term deliveries (greater than 38 weeks) will be enrolled. Medical/obstetric history and pregnancy outcomes will be recorded. Maternal blood, urine and cervical cells (enrollment); cord blood and placental biopsy (delivery) will be collected.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 705 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02441335
The ClinicalTrials.gov registry entry for NCT02441335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 705 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02441335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02441335 about?
NCT02441335 is a clinical study titled "CellulaR Injury and Preterm Birth". The goal of this study is to examine how cellular dysfunction can lead to preterm birth. Women with singleton pregnancies with spontaneous preterm labor, preterm premature rupture of membranes, and cervical insufficiency (20 to 36-6/7 weeks gestation), and term deliveries (greater than 38 weeks) wil...
What is the current status of trial NCT02441335?
This trial is currently completed. The enrollment target is 705 participants. The study started on 2015-01. Estimated completion is 2019-08-01.
Who is sponsoring clinical trial NCT02441335?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.